HOYA Vision Care Announces New Sensity® 2 Light-Adaptive Lenses with Nearly Twice the Fadeback Speed

Advanced lens technology offers nearly twice the fadeback speed of its first generation Demand for light-adaptive lenses increases as two-thirds of patients now report sensitivity

A significant improvement compared to the previous generation of Sensity lenses, Sensity 2 lenses offer nearly twice the fadeback speed – approximately 42 percent faster.

Building on more than five years of success with its first-generation Sensity® lenses, HOYA Vision Care has created a product that rapidly darkens to a category 3 sun lens tint, fades back nearly twice as fast to a clear lens indoors, and still offers the same comfort, convenience, and protection as the entire Sensity family – with 100% UV protection, reduced glare from the sun when activated, and blue light protection indoors and outdoors2.

Available today, Sensity 2 lenses come in three intense natural color options: Silver Grey, Bronze Brown, and Emerald Green. They are compatible with HOYA’s Single Vision, Backside Progressives, and iD designs, as well as all of HOYA’s current antireflective treatments.

Two key technological innovations underlie the improved performance of the lenses: Stabilight Technology provides consistent performance and UV protection no matter the climate, cold or warm. Precision Technology ensures a microscopically accurate spin-coating process, creating superior adhesion for great scratch resistance.

“We are excited to bring Sensity 2 lenses to the market, offering an even faster fadeback that ECPs and their patients will greatly benefit from,” said Nick LaManna, Director of Product Management for HOYA Vision Care, North America. “Our continuous focus on improving our products has made us an industry leader in light-adaptive lens technology, and these are no exception.”

Interested ECPs can ask their HOYA Territory Sales Manager for more information about Sensity 2 light-adaptive lenses. Additionally, Visionary Alliance members are eligible to earn points when they choose Sensity 2 for their patients’ vision needs.


1. Harris Interactive Consumer Market Research Study, Global Report, Nov 2019: Usage Behavior When Outdoors

2. Based on internal testing of average light transmission between 381nm-500nm compared to standard clear lens

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version